Robinson Eric, Logan Charles, Chiu Stephen, Husain Nazia, Cuttica Michael J, Mongé Michael C, Malaisrie S Christopher
Division of Cardiac Surgery, Northwestern University Feinberg School of Medicine and Northwestern Medicine, Chicago, Illinois, USA.
Division of Cardiology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
JACC Case Rep. 2025 Mar 5;30(5):103069. doi: 10.1016/j.jaccas.2024.103069.
There is no consensus on the preferred conduit for right ventricular outflow tract (RVOT) reconstruction for congenital cardiac disease.
We present a case of a 21-year-old woman with history of tetralogy of Fallot presenting with recurrent graft thrombosis and pulmonary emboli in the setting of RVOT reconstruction with a 20-mm expanded polytetrafluoroethylene (ePTFE) valved conduit (GORE PV1, W.L. Gore & Associates). A diagnosis of chronic thromboembolic pulmonary hypertension was made, and the patient underwent pulmonary endarterectomy and conduit exchange with a pulmonary homograft.
The novelty and clinical significance of this report lies in the confirmation of thrombosis of a large-diameter ePTFE valved pulmonary conduit (20 mm) and its implications for monitoring and need for further optimization of thromboprophylaxis strategies in this population.
对于先天性心脏病右心室流出道(RVOT)重建的首选管道尚无共识。
我们报告一例21岁法洛四联症女性患者,在使用20毫米膨体聚四氟乙烯(ePTFE)带瓣管道(GORE PV1,W.L. Gore & Associates公司)进行RVOT重建的情况下,出现移植血管反复血栓形成和肺栓塞。诊断为慢性血栓栓塞性肺动脉高压,患者接受了肺动脉内膜剥脱术,并更换为同种异体肺动脉移植物。
本报告的新颖性和临床意义在于证实了大口径(20毫米)ePTFE带瓣肺动脉管道的血栓形成,及其对该人群监测的意义以及进一步优化血栓预防策略的必要性。